WILSON D TRAVIS has a total of 12 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ASCENDIS PHARMA ONCOLOGY DIV A/S, 7 HILLS INTERESTS LLC and LABORATORIOS LETI S L UNIPERSONAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Enzymes | |
#5 | Heterocyclic compounds | |
#6 | Microorganisms | |
#7 | Acyclic or carbocyclic compounds | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Wilson D Travis | 12 |
#2 | Mead Elizabeth | 1 |
#3 | Andersen Marc W | 1 |
#4 | Borow Kenneth | 1 |
#5 | Hale Sharon | 1 |
#6 | Kloner Robert A | 1 |
Publication | Filing date | Title |
---|---|---|
US2019022167A1 | Methods and compositions for the prevention and treatment of duchenne muscular dystrophy | |
US2016199437A1 | Therapeutic compositions including iron chelators and uses thereof | |
US2016279255A1 | THERAPEUTIC COMPOSITIONS INCLUDING MODULATORS OF deltaPKC AND/OR epsilonPKC, AND USES THEREOF | |
WO2016004441A1 | Methods for the prevention or treatment of acute myocardial infarction injury |